Filing Flows › iRhythm Holdings (IRTC) › Q3 2026 › vs Q2 2026
iRhythm Holdings (IRTC) Q3 2026 vs Q2 2026 (quarter over quarter)
iRhythm Holdings's revenue fell $2.6M (-1%) from $224M in Q2 2026 to $222M in Q3 2026. The biggest changes: Contracted third-party payors −$3.0M (-3%); Non-contracted third-party payors +$2.1M (+15%); CMS −$1.3M (-2%).
iRhythm Holdings, Q3 2026: revenue $222M (+15% year over year), operating margin -14.7%, net loss $29.9M, operating cash flow $4.4M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Contracted third-party payors | $111M | $114M | −$3.0M | -3% |
| CMS | $57.2M | $58.5M | −$1.3M | -2% |
| Customer A | $37.4M | $37.8M | −$356K | -0.9% |
| Non-contracted third-party payors | $16.1M | $14.1M | $2.1M | +15% |
| Revenue | $222M | $224M | −$2.6M | -1% |
| Other income, net | $2.7M | $2.2M | $543K | +25% |
| Net loss | $29.9M | $381K | $29.5M | 78× |
| Costs & expenses | $254M | $227M | $27.4M | +12% |
| Operating costs | $254M | $227M | $27.4M | +12% |
| Cost of revenue | $57.1M | $61.0M | −$3.9M | -6% |
| Research & development | $20.6M | $19.8M | $756K | +4% |
| SG&A | $126M | $132M | −$6.0M | -5% |
| Other operating costs | $50.8M | $14.2M | $36.6M | +257% |
| Operating cash sources | $34.3M | $51.5M | −$17.2M | -33% |
| Depreciation & amortization | $5.3M | $5.2M | $100K | +2% |
| Share-based compensation | $19.5M | $20.0M | −$549K | -3% |
| Working capital & other | $9.5M | $26.2M | −$16.7M | -64% |
| Net loss absorbed | $29.9M | $381K | $29.5M | 78× |
| Operating cash flow | $4.4M | $51.1M | −$46.6M | -91% |
| Capital expenditures | $16.0M | $13.6M | $2.4M | +18% |
| Negative free cash flow (OCF − capex) | $11.5M | −$37.5M | $49.1M | — |
Questions
How much did iRhythm Holdings's revenue grow quarter over quarter in Q3 2026?
iRhythm Holdings's revenue fell $2.6M (-1%) from $224M in Q2 2026 to $222M in Q3 2026.
What drove iRhythm Holdings's revenue change in Q3 2026?
Contracted third-party payors −$3.0M (-3%); Non-contracted third-party payors +$2.1M (+15%); CMS −$1.3M (-2%).